Title: Conde-Ceide S, et al. Discovery of VU0409551/JNJ-46778212: An mGlu5 Positive Allosteric Modulator Clinical Candidate Targeting Schizophrenia. ACS Med Chem Lett. 2015 May 20;6(6):716-20.
1169490-60-1 | 7-chloro-1-benzofuran-3-carboxylic acid | AA01C1BN | MFCD21234549
1909306-61-1 | 5,7-dihydro-4H-spiro[1,3-benzothiazole-6,4'-oxane]-2-amine | AA01C1G7 | MFCD29047331
1520596-78-4 | 4-methyl-2-({[methyl(propyl)carbamoyl]amino}methyl)pentanoic acid | AA01C1L0 | MFCD22915065
1909313-59-2 | 3-(pyrrolidine-1-carbonyl)piperidin-3-ol hydrochloride | AA01C1PR | MFCD29047436
1698527-10-4 | tert-Butyl n-(2-[(3-bromo-5-fluorophenyl)methyl]-3-hydroxypropyl)carbamate | AA01C1UA | MFCD29047486
1909337-59-2 | 3-methoxyspiro[3.3]heptan-1-one | AA01C1YY | MFCD29047538
1300022-26-7 | ethyl 2-[(dimethylamino)methylidene]-4,4-diethoxy-3-oxobutanoate | AA01C23S | MFCD29762686
1523376-59-1 | 2-amino-2-(1-methyl-1H-pyrazol-5-yl)ethan-1-ol | AA01C282 | MFCD26938122
1934399-85-5 | 5,6,7,8-Tetrahydro-1,8-naphthyridine-2-carboxamide | AA01C2CT | MFCD30180337
79802-79-2 | 1,3,3-trimethylcyclohexan-1-ol | AA01C2GW | MFCD20328707